Han Biomedical (6999.TWO) Stock Price
Han Biomedical Price
Revenue has compounded at 10.8% per year over the past 2 years to 115.30 M TWD. Earnings per share have grown at 15.0% per year over the last 2 years. Han Biomedical's net margin stands at 21.1%, up from 19.9% several years earlier. Han Biomedical currently offers a dividend yield of about 1.40%. The payout ratio is around 35% of earnings.
Han Biomedical stock price
Han Biomedical business model & stock analysis
Frequently asked questions about Han Biomedical
Converted at the current exchange rate, the Han Biomedical share trades at 0.78 EUR (28.00 TWD).
The revenue cannot currently be calculated for Han Biomedical.
The profit cannot currently be calculated for Han Biomedical.
The P/E ratio cannot be calculated for Han Biomedical at the moment.
The P/S cannot be calculated for Han Biomedical currently.
The Eulerpool Quality Score for Han Biomedical is 2/10.
The ISIN of Han Biomedical is TW0006999006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Han Biomedical is 6999.TWO. The ticker symbol is used to trade Han Biomedical shares on the stock exchange.
Han Biomedical stock
Han Biomedical Peer Group
All fundamentals and in-depth analysis of Han Biomedical
Our stock analysis for Han Biomedical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Han Biomedical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.